نتایج جستجو برای: ovarian tumor cell line

تعداد نتایج: 2250639  

Amin Soleymanian Fahimeh Ramezani Tehrani, Fatemeh Rezayat Mehri Hajiaghayi Mehrnaz Mesdaghi Nazanin Ghasemi

Background: Polycystic Ovarian Syndrome (PCOS) is a pro-inflammatory condition that supports the development of metabolic aberration and ovarian dysfunction. Chronic inflammation and the increased levels of androgens in this group of patients and their impact on the immune system may increase the risk of developing malignancies, including ovarian cancer. Thus, we interacted ovarian tumor cells ...

2015
Lihong Mo Vendula Pospichalova Zhiqing Huang Susan K. Murphy Sturgis Payne Fang Wang Margaret Kennedy George J. Cianciolo Vitezslav Bryja Salvatore V. Pizzo Robin E. Bachelder Irina V Lebedeva

Chemotherapy resistance is the major reason for the failure of ovarian cancer treatment. One mechanism behind chemo-resistance involves the upregulation of multidrug resistance (MDR) genes (ABC transporters) that effectively transport (efflux) drugs out of the tumor cells. As a common symptom in stage III/IV ovarian cancer patients, ascites is associated with cancer progression. However, whethe...

2012
DONGDONG WANG YASUSHI SAGA HIROAKI MIZUKAMI NAOTO SATO HIROAKI NONAKA HIROYUKI FUJIWARA YUJI TAKEI SHIZUO MACHIDA OSAMU TAKIKAWA KEIYA OZAWA MITSUAKI SUZUKI

This study examined the role of the immuno-suppressive enzyme indoleamine-2,3-dioxygenase (IDO) in ovarian cancer progression, and the possible application of this enzyme as a target for ovarian cancer therapy. We transfected a short hairpin RNA vector targeting IDO into the human ovarian cancer cell line SKOV-3, that constitutively expresses IDO and established an IDO downregulated cell line (...

Journal: :Cancer research 2002
Chris J Scotton Julia L Wilson Kate Scott Gordon Stamp George D Wilbanks Simon Fricker Gary Bridger Frances R Balkwill

Of 14 chemokine receptors investigated, only CXCR4 was expressed on ovarian cancer cells [C. J. Scotton et al., Cancer Res., 61: 4961-4965, 2001]. To further understand the role of this chemokine receptor in ovarian tumor biology, we studied the action of its ligand, CXCL12 (stromal cell-derived factor 1), on the CXCR4-expressing ovarian cancer cell lines IGROV. Ligand stimulation of the CXCR4 ...

2002
Chris J. Scotton Julia L. Wilson Kate Scott Gordon Stamp George D. Wilbanks Simon Fricker Gary Bridger Frances R. Balkwill

Of 14 chemokine receptors investigated, only CXCR4 was expressed on ovarian cancer cells [C. J. Scotton et al., Cancer Res., 61: 4961–4965, 2001]. To further understand the role of this chemokine receptor in ovarian tumor biology, we studied the action of its ligand, CXCL12 (stromal cell-derived factor 1), on the CXCR4-expressing ovarian cancer cell lines IGROV. Ligand stimulation of the CXCR4 ...

Journal: :veterinary research forum 0
ghasem farjanikish department of pathobiology, faculty of veterinary medicine, lorestan university, khorram abad, iran ahmad oryan department of pathobiology, school of veterinary medicine, shiraz university, shiraz, iran

leydig cell tumor as a sex-cord stromal tumor is a relatively uncommon ovarian tumorin bitch. a 10-year-old female german shepherd dog was presented because of protrusion of a large tumor-like mass of 16 × 14 × 7 cm in dimensions from her vagina. after stabilization of the patient, the mass was removed surgically and concurrent ovariohysterectomy was also performed. macroscopically, the healthy...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1994
R Farias-Eisner M P Sherman E Aeberhard G Chaudhuri

When cultured in vitro, peritoneal macrophages, obtained from mice previously inoculated with bacillus Calmette-Guérin, release nitric oxide, which is cytostatic and/or cytolytic for tumor cells. However, it is not known whether nitric oxide has antitumor effects in vivo. Here we demonstrate that nitric oxide is an important mediator of host resistance to syngeneic and xenogeneic ovarian tumor ...

Journal: :iranian journal of pharmaceutical sciences 0
nastaran nikounezhad maryam nakhjavani adepartment of toxicology and pharmacology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, iran. farshad hosseini shirazi pharmaceutical sciences research center, shahid beheshti university of medical sciences, tehran, iran.

ovarian cancer is the most lethal gynecological cancer in which cisplatin-based treatment plays fundamental role as the first line chemotherapy option. however, development of platinum-resistance is a critical and poorly understood problem in ovarian cancer treatment. although in vitro generation of platinum-resistant ovarian cancer cell lines is a long established approach to uncover the molec...

اسلامی, بابک , افضل آقایی, منور , حسن‌زاده مفرد, ملیحه , میرتیموری, معصومه , همایی, فاطمه ,

Background: Ovarian sex cord-stromal tumors (SCST) account for rare ovarian malignancy. These tumors are 5-8% of all ovarian neoplasms. The most common type of sex cord ovarian tumors is granulosa cell tumor (GCT). In this study our purpose was to have a look at some of clinicopathologic aspects and treatment results of these tumors. Methods: In a retrospective study, all documents of patients ...

2014
CHENHONG LUO KIYOSUMI SHIBATA SHIRO SUZUKI HIROAKI KAJIYAMA TAKESHI SENGA YOSHIHIRO KOYA MINA DAIMON MAMORU YAMASHITA FUMITAKA KIKKAWA

Glypican-3 (GPC3) is specifically expressed in ovarian clear cell carcinoma (OCCC), hepatocellular carci-noma (HCC), and melanoma and lung cancer. GPC3 is being explored as a potential candidate for OCCC and HCC immunotherapy. As a tumor-associated antigen, induction of immune response of GPC3 in ovarian cancer remains elusive. We established a GPC3 transgenic mouse ovarian cancer cell line, OV...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید